Left Menu
Development News Edition

Brazil approves human trials for third COVID-19 vaccine

A vaccine developed by the University of Oxford and AstraZeneca entered clinical trials in Brazil in June. The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful.

Reuters | Brasilia | Updated: 22-07-2020 02:26 IST | Created: 22-07-2020 02:25 IST
Brazil approves human trials for third COVID-19 vaccine
Representative Image Image Credit: ANI

Brazil on Tuesday approved clinical trials starting in August for a potential COVID-19 vaccine under joint development by U.S. pharmaceutical company Pfizer and Germany's BioNTech - the third such vaccine to be tested in the country. With more than 2.1 million confirmed cases of the novel coronavirus, Brazil has the world's worst outbreak outside the United States, making it prime testing grounds for vaccines.

"We are proud to have Brazilian volunteers participating in this global effort, which could play a critical role in the fight against COVID-19," said Edson Moreira, who will lead the Pfizer/BioNTech trial, according to a company statement. Brazilian health regulator Anvisa had previously approved trials for possible vaccines developed in the U.K. and China.

On Tuesday, the first Brazilian volunteer was injected with a possible coronavirus vaccine developed by China's Sinovac Biotech in Sao Paulo. A vaccine developed by the University of Oxford and AstraZeneca entered clinical trials in Brazil in June.

The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful. Interim Health Minister Eduardo Pazuello said on Tuesday that negotiations are underway with U.S. biotech firm Moderna Inc for Brazil to get priority in purchasing a potential COVID-19 vaccine the company is developing.

Pazuello said Brazil already has an understanding with AstraZeneca for the firm to deliver 30 million doses of its potential vaccine. Sinovac has agreed to deliver enough vaccine to immunize 60 million Brazilians if its vaccine is proven effective.

Brazil is also developing possible vaccines domestically, which are still in pre-clinical testing stages.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

India IT spending to grow 6.8% in 2021: Gartner

Indias IT spending is projected to grow 6.8 per cent to USD 88.8 billion in 2021 over the previous year, research firm Gartner said on Monday.In 2020, India IT spending declined 2.7 per cent as CIOs prioritised spending on technology and se...

EU holds off on new Russia sanctions after Navalny protest arrests

The European Union will hold off from imposing fresh sanctions on Russian individuals on Monday, EU diplomats said, despite the arrest of more than 3,000 people across Russia on Saturday to demand the release of Kremlin critic Alexei Navaln...

SC seeks CBI's reply on Kerala’s Life Mission Project’s plea against probe on corruption charges

The Supreme Court on Monday sought response from the CBI on a plea filed by CEO of Life Mission Project of the Kerala government challenging the High Court order allowing probe by central agency into the corruption allegations in the States...

NCW to challenge Bombay HC judgment on sexual assault

The National Commission for Women on Monday said it will challenge in the Supreme Court the Bombay High Court judgment which said groping without skin to skin contact is not sexual assault as defined under the Protection of Children from Se...

Give Feedback